Leaders in Pharmaceutical Business Intelligence (LPBI) Group

9:00 – 9:10 – 6/13/2014, Tyler Jacks, Director, David H. Koch Institute for Integrative Cancer

LIVE from Kresge Auditorium @ MIT

Reporter: Aviva Lev-Ari, PhD, RN

Key points captured from Tyler Jacks

• highlight cancer innovations – 40 years to Cancer Research at MIT, before the Koch buildging erectered 3 1/2 years ago
• regulatory roles in disese a management
• biology & technology: co habitation and collaboration of scientists and Engineer
• Phil Sharp recruited from Cold Springs Harbor working with Watson, Institute Prof. and Biology Prof.
• sponsors and many ventors sponsored the event

9:00 – 9:10, 6/13/2-14 – Tyler Jacks, Director, David H. Koch Institute for Integrative Cancer

@MIT – Summer Symposium 2014: RNA Biology, Cancer and Therapeutic Implications, June 13, 2014 8:30AM – 4:30PM, Kresge Auditorium @MIT

http://ki.mit.edu/news/symposium

REALTIME event coverage for the Scientific Media by Dr.  A. Lev-Ari 

in Open Access Scientific Journal of Leaders in Pharmaceutical Business Intelligence (LPBI)

http://pharmaceuticalintelligence.com

#pharmaIT,#BIOIT,#technews,#curation,#pharmanews,#mobilehealth,#mhealth,#science,#science2_0,#healtcare,#BIOIT14,#Boston ,@Biotech News,@MhealthForAll,@mHealthAlliance,@HCtrends,@mobilehealth360,@science 2_0